Equine Respiratory Relief

Manufacturer: W LAST CC | FEELGOOD HEALTH
Effective date: 2011-11-22
Label type: OTC ANIMAL DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-06-01 02:03:27

Label at a glance#

ProductEquine Respiratory Relief

Active ingredientACONITUM NAPELLUS, ATROPA BELLADONNA, CALCIUM SULFIDE, SILICON DIOXIDE, MERCURIUS SOLUBILIS, SULFUR

Label structure10 sections

Contacts and useful links#

PhoneLabel contact1.877.289.1235

PhoneLabel contact1.561.999.8857

Websitewww.petalive.com

www.petalive.com

Label contents#

Full prescribing information#

OTC - PURPOSE SECTION

Homeopathic Strangles support

INDICATIONS & USAGE SECTION

Indications: Homeopathic remedy for upper respiratory health and Strangles in horses.

DOSAGE & ADMINISTRATION SECTION

Dosage: Sprinkle a capful of pilules directly into the mouth or offer on the hand. Initial dose: Every 30 minutes for up to 10 doses. Thereafter, 3 times daily until symptoms subside. Concurrent use of EQuine Immunity Booster™ is recommended for immune support.

GENERAL PRECAUTIONS SECTION

Caution: Consult your vet if symptoms persist or worsen. Isolate horses and all tack/equipment until infection has cleared. Keep this and all medicines out of reach of children.

OTC - ACTIVE INGREDIENT SECTION

Ingredients: Aconitum nap (6C) (HPUS), Belladonna (30C) (HPUS), Hepar sulph. (30C) (HPUS), Silicea (6X) (HPUS), Merc sol (6C) (HPUS), Sulphur (6C) (HPUS)

INACTIVE INGREDIENT SECTION

Sucrose (inactive ingredient).

WARNINGS SECTION

Contains no gluten, artificial flavors, colors or preservatives.

INFORMATION FOR PATIENTS SECTION

All Native Remedies health products are especially formulated by experts in the field of natural health and are manufactured according to the highest pharmaceutical standards for maximum safety and effectiveness. For more information, visit us at www.petalive.com

Distributed by

Native Remedies, LLC

6531 Park of Commerce Blvd.

Suite 160

Boca Raton, FL 33487

Phone: 1.877.289.1235

International: + 1.561.999.8857

The letters HPUS indicate that the component(s) in this product is (are) officially monographed in the Homeopathic Pharmacopoeia of the United States.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

bottle label

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all medicines out of reach of children.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
bee4fa8d-8d82-423a-a0b5-40a89dd13a99	Product name	1	20250618
e0d2eb29-08bd-4bba-90d1-c91c68a38767	Product name	4	20250516
30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2	Product name	5	20250304
334fe8d2-68fb-4331-a576-420e302ec069	Product name	7	20240320
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
e92765c1-be81-432a-b909-1b10777ec378	Product name	1	20190208
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
0441a8f5-3835-497c-aedd-bc78cba56b2a	Product name	1	20150317
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50048-072-00	Equine Respiratory Relief	200000 mg in 1 BOTTLE, GLASS	GRANULE	200000		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50048-072	EQUINE RESPIRATORY RELIEF (ACONITUM NAP, BELLADONNA, HEPAR SULPH., SILICEA, MERC SOL , SULPHUR ) GRANULE [W LAST CC]	1	1 package rows	20111130_201c2d5a-7de4-4387-a0fa-5d620fb72351.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ACONITUM NAPELLUS	ACTIVE INGREDIENT	U0NQ8555JD	1
ATROPA BELLADONNA	ACTIVE INGREDIENT	WQZ3G9PF0H	1
CALCIUM SULFIDE	ACTIVE INGREDIENT	1MBW07J51Q	1
MERCURIUS SOLUBILIS	ACTIVE INGREDIENT	324Y4038G2	1
SILICON DIOXIDE	ACTIVE INGREDIENT	ETJ7Z6XBU4	1
SULFUR	ACTIVE INGREDIENT	70FD1KFU70	1
ACONITUM NAPELLUS	ACTIVE MOIETY	U0NQ8555JD	1
ATROPA BELLADONNA	ACTIVE MOIETY	WQZ3G9PF0H	1
CALCIUM CATION	ACTIVE MOIETY	2M83C4R6ZB	1
MERCURIUS SOLUBILIS	ACTIVE MOIETY	324Y4038G2	1
SILICON DIOXIDE	ACTIVE MOIETY	ETJ7Z6XBU4	1
SULFUR	ACTIVE MOIETY	70FD1KFU70	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

Equine Respiratory Relief
Aconitum nap, Belladonna, Hepar sulph., Silicea, Merc sol , Sulphur
ACONITUM NAPELLUS
ATROPA BELLADONNA
CALCIUM SULFIDE
CALCIUM CATION
SILICON DIOXIDE
MERCURIUS SOLUBILIS
SULFUR
SUCROSE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
50048-072	50048-072-00

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ACONITUM NAPELLUS	U0NQ8555JD	ACTIB
ATROPA BELLADONNA	WQZ3G9PF0H	ACTIB
CALCIUM SULFIDE	1MBW07J51Q	ACTIB
SILICON DIOXIDE	ETJ7Z6XBU4	ACTIB
MERCURIUS SOLUBILIS	324Y4038G2	ACTIB
SULFUR	70FD1KFU70	ACTIB
SUCROSE	C151H8M554	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 48 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, EMULSION / INTRAVENOUS		970 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	900 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		308 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / SUBCUTANEOUS	47.75 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	9.4 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / BUCCAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / RECTAL	35.42 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		2000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTABLE, LIPOSOMAL / INTRAVENOUS		7560 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / INTRAVENOUS		1950 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 3 · 52 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Hylands Leg Cramps With Arnica	ACONITUM NAPELLUS	Hyland's Consumer Health Inc.	142ea9b2-63f9-6a04-e063-6394a90a7fc9	2026-08-12	Warnings	Name fallback generic name: ACONITUM NAPELLUS
Aconitum napellus 7101	ACONITUM NAPELLUS	Professional Complementary Health Formulas	9d04cb5d-cafa-4a64-bd6e-5724b9ee36ef	2026-01-08	Warnings	Name fallback generic name: ACONITUM NAPELLUS
Aconitum napellus	ACONITUM NAPELLUS	Boiron	840f7e2c-d7a3-d2ac-e053-2991aa0ac04a	2025-09-10		Name fallback generic name: ACONITUM NAPELLUS
Aconitum napellus	ACONITUM NAPELLUS	Boiron	84b090d3-01cc-4b6d-e053-2991aa0ab211	2025-09-10		Name fallback generic name: ACONITUM NAPELLUS
Aconitum napellus	ACONITUM NAPELLUS	Boiron	840f3ea5-a57f-34f2-e053-2991aa0aa1df	2025-09-10		Name fallback generic name: ACONITUM NAPELLUS
Aconitum napellus	ACONITUM NAPELLUS	Boiron	84b23237-c6ef-3231-e053-2a91aa0aa569	2025-09-10		Name fallback generic name: ACONITUM NAPELLUS
Aconitum napellus	ACONITUM NAPELLUS	Boiron	840f4776-c8dc-655f-e053-2991aa0ad7b0	2025-09-10		Name fallback generic name: ACONITUM NAPELLUS
Aconitum napellus	ACONITUM NAPELLUS	Boiron	84b20bf1-846c-4a10-e053-2991aa0abefe	2025-09-10		Name fallback generic name: ACONITUM NAPELLUS
Aconitum napellus	ACONITUM NAPELLUS	Boiron	84b1d915-97a1-4535-e053-2a91aa0aa464	2025-09-10		Name fallback generic name: ACONITUM NAPELLUS
Aconitum napellus	ACONITUM NAPELLUS	Boiron	84b29e49-ea6a-8519-e053-2991aa0a7cd1	2025-09-10		Name fallback generic name: ACONITUM NAPELLUS
Aconitum napellus	ACONITUM NAPELLUS	Boiron	840eea30-7779-d232-e053-2a91aa0ac596	2025-09-10		Name fallback generic name: ACONITUM NAPELLUS
Aconitum napellus	ACONITUM NAPELLUS	Boiron	8860ffcb-a889-4deb-e053-2995a90ac080	2025-09-10		Name fallback generic name: ACONITUM NAPELLUS
Aconitum napellus	ACONITUM NAPELLUS	Boiron	840f0eec-a05a-7c6e-e053-2991aa0aa6c6	2025-09-10		Name fallback generic name: ACONITUM NAPELLUS
Bestmade Natural Products Aconitum Napellus	ACONITUM NAPELLUS	Bestmade Natural Products	2993aeb3-a327-1b94-e063-6394a90a6596	2025-05-27	Warnings	Name fallback generic name: ACONITUM NAPELLUS
Aconitum Napellus 30X	ACONITUM NAPELLUS	Laboratoire Schmidt-Nagel Inc.	32fd6811-9ec9-7787-e063-6294a90aed2d	2025-05-20	Warnings	Name fallback generic name: ACONITUM NAPELLUS
Arnica montana	ACONITUM NAPELLUS	Newton Laboratories, Inc.	9e3be074-b2cd-9b1f-e053-2a95a90ac7b2	2025-02-10	Warnings	Name fallback generic name: ACONITUM NAPELLUS
Aconitum napellus	ACONITUM NAPELLUS	Hahnemann Laboratories, Inc.	9a01c5f5-e9d9-5ac1-e053-2995a90a137e	2025-01-09		Name fallback generic name: ACONITUM NAPELLUS
Aconitum napellus	ACONITUM NAPELLUS	Hahnemann Laboratories, Inc.	9a01ab86-eed0-5f1d-e053-2a95a90aff56	2025-01-09		Name fallback generic name: ACONITUM NAPELLUS
Aconitum napellus	ACONITUM NAPELLUS	Hahnemann Laboratories, Inc.	9a020fba-31b0-3b89-e053-2a95a90a9be6	2025-01-09		Name fallback generic name: ACONITUM NAPELLUS
Aconitum napellus	ACONITUM NAPELLUS	Hahnemann Laboratories, Inc.	9a022465-f2b8-b503-e053-2a95a90aec7d	2025-01-09		Name fallback generic name: ACONITUM NAPELLUS

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.